The neuropeptide 26RFa is expressed in human prostate cancer and stimulates the neuroendocrine differentiation and the migration of androgeno-independent prostate cancer cells

European Journal of Cancer

Volumn 49, Issue 2, 2013, Pages 511-519

  Alonzeau, Jessy ^a   Alexandre, David ^a   Jeandel, Lydie ^a   Courel, Maïté ^a   Hautot, Coralie ^a   Yamani, Fatima Zohra El ^b   Gobet, Françoise ^c   Leprince, Jérôme ^a   Magoul, Rabia ^b   Amarti, Afaf ^d   Pfister, Christian ^c   Yon, Laurent ^a   Anouar, Youssef ^a   Chartrel, Nicolas ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b Université Sidi Mohammed Ben Abdellah   (Morocco)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d HASSAN II UNIVERSITY HOSPITAL   (Morocco)

Author keywords

Advanced prostate cancer; G protein coupled receptor; Neuroendocrine differentiation; Neuropeptide

Indexed keywords

ANDROGEN; CHROMOGRANIN A; GPR103 RECEPTOR; NEUROPEPTIDE; NEUROPEPTIDE 26RFA; NEUROPEPTIDE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; NEURITE; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANDROGENS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASMS, HORMONE-DEPENDENT; NEUROENDOCRINE CELLS; NEUROPEPTIDES; PROSTATIC NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84872112695     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.05.028     Document Type: Article

References (31)

1. E.C. Nelson Clinical implications of neuroendocrine differentiation in prostate cancer Prostate Cancer Prostatic Dis 10 2007 6 14
2. H. Bonkhoff Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status Prostate Suppl 8 1998 18 22
3. H. Bonkhoff, U. Stein, and K. Remberger Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells Hum Pathol 26 1995 167 170
4. A.H. Shariff, and M.H. Ather Neuroendocrine differentiation in prostate cancer Urology 68 2006 2 8
5. F. Cuttitta Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer Nature 316 1985 823 826
6. S. Guha, J.A. Lunn, C. Santiskulvong, and E. Rozengurt Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1 Cancer Res 63 2003 2379 2387
7. J. Hansson, and P.A. Abrahamsson Neuroendocrine pathogenesis in adenocarcinoma of the prostate Ann Oncol 12 Suppl. 2 2001 S145 52
8. F. Bruzzone Anatomical distribution and biochemical characterization of the novel RFamide peptide 26RFa in the human hypothalamus and spinal cord J Neurochem 99 2006 616 627
9. N. Chartrel Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity Proc Natl Acad Sci USA 100 2003 15247 15252
10. N. Chartrel The RFamide neuropeptide 26RFa and its role in the control of neuroendocrine functions Front Neuroendocrinol 32 2011 387 397
11. S. Fukusumi A new peptidic ligand and its receptor regulating adrenal function in rats J Biol Chem 278 2003 46387 46395
12. Y. Jiang Identification and characterization of a novel RF-amide peptide ligand for orphan G-protein-coupled receptor SP9155 J Biol Chem 278 2003 27652 27657
13. B. Lectez The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleus Endocrinology 150 2009 2342 2350
14. S. Takayasu A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice Proc Natl Acad Sci USA 103 2006 7438 7443
15. V.M. Navarro Novel role of 26RFa, a hypothalamic RFamide orexigenic peptide, as putative regulator of the gonadotropic axis J Physiol 573 2006 237 249
16. S.R. Patel Pyroglutamylated RFamide peptide 43 stimulates the hypothalamic-pituitary-gonadal axis via gonadotropin-releasing hormone in rats Endocrinology 149 2008 4747 4754
17. H. Baribault The G-protein-coupled receptor GPR103 regulates bone formation Mol Cell Biol 26 2006 709 717
18. Y. Anouar Identification of a novel secretogranin II-derived peptide (SgII(187-252)) in adult and fetal human adrenal glands using antibodies raised against the human recombinant peptide J Clin Endocrinol Metab 83 1998 2944 2951
19. T.C. Yuan, S. Veeramani, and M.F. Lin Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells Endocr Relat Cancer 14 2007 531 547
20. P. Rocchi Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines Cancer Res 61 2001 1196 1206
21. M. Sumitomo Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling J Clin Invest 106 2000 1399 1407
22. M. Ruscica, E. Dozio, M. Motta, and P. Magni Role of neuropeptide Y and its receptors in the progression of endocrine-related cancer Peptides 28 2007 426 434
23. B. Collado, M.G. Sanchez, I. Diaz-Laviada, J.C. Prieto, and M.J. Carmena Vasoactive intestinal peptide (VIP) induces c-fos expression in LNCaP prostate cancer cells through a mechanism that involves Ca2+ signalling. Implications in angiogenesis and neuroendocrine differentiation Biochim Biophys Acta 1744 2005 224 233
24. D. Farini, A. Puglianiello, C. Mammi, G. Siracusa, and C. Moretti Dual effect of pituitary adenylate cyclase activating polypeptide on prostate tumor LNCaP cells: short- and long-term exposure affect proliferation and neuroendocrine differentiation Endocrinology 144 2003 1631 1643
25. M.G. Juarranz Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors Cell Signal 13 2001 887 894
26. I. Abasolo, L.M. Montuenga, and A. Calvo Adrenomedullin prevents apoptosis in prostate cancer cells Regul Pept 133 2006 115 122
27. C. Berenguer Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells Oncogene 27 2008 506 518
28. M. Zhong, M.L. Boseman, A.C. Millena, and S.A. Khan Oxytocin induces the migration of prostate cancer cells: involvement of the Gi-coupled signaling pathway Mol Cancer Res 8 2010 1164 1172
29. P.D. Deeble, D.J. Murphy, S.J. Parsons, and M.E. Cox Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells Mol Cell Biol 21 2001 8471 8482
30. S. Zelivianski Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype Biochim Biophys Acta 1539 2001 28 43
31. L.F. Lee, J. Guan, Y. Qiu, and H.J. Kung Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase Mol Cell Biol 21 2001 8385 8397